The Incannex Healthcare Ltd (ASX: IHL) share price won’t be going anywhere on Tuesday.
This comes as the company requested that its shares be placed in a trading halt.
At the time of writing, the medicinal cannabis company’s shares are frozen at 70 cents apiece.
Why is the Incannex share price halted?
At market open, the company requested trading in its shares be halted while it prepared an announcement.
According to the release, the company is planning to make an announcement regarding a potential business acquisition transaction.
At this stage, the details remain unknown as to which company is subject to a possible takeover.
Incannex has requested that the trading halt remains in place until Thursday 24 March or following the release of the announcement, whichever comes first.
What does Incannex do?
Founded in 2001, Incannex is a clinical-stage pharmaceutical company developing novel medicinal cannabinoid compounds and psychedelic therapies for unmet needs.
This includes treatment of generalised anxiety disorder (GAD), obstructive sleep apnoea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, and inflammatory bowel disease.
Currently, the company is pursuing United States Food and Drug Administration (FDA) approval of all its drug candidates.
Once approved, Incannex is seeking to expand its products in other regions such as Europe, Japan, Australia, and Israel.
Incannex share price summary
Over the past 12 months, the Incannex share price has surged by more than 230% following its IHL-42X positive phase 2 clinical trial results.
Although, since the start of the year, its shares have recorded wild swings of more than 40% in either direction.
The company’s shares are up 12% in 2022.
Based on valuation grounds, Incannex has a market capitalisation of roughly $847 million, with approximately 1.2 billion shares outstanding.
The post Here’s why the Incannex (ASX:IHL) share price is on ice today appeared first on The Motley Fool Australia.
Should you invest $1,000 in Incannex right now?
Before you consider Incannex, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Incannex wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- The Incannex (ASX:IHX) share price is up a whopping 50% in a week. What’s the deal?
- What’s going on with the Incannex (ASX:IHL) share price today?
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/aky8s7S
Leave a Reply